drugset / Trial / NCT02454868

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

NCT02454868

NaSingle-groupOpen-labelSupportive care

Summary

Introduction: remifentanil's optimal dose for children intubation without neuromuscular blockade is unknown. Method: phase IV adaptative trial using Dixon's up-and-down method for modeling remifentanil's dose-response curve for adequate intubation conditions as defined by previous studies.

Timeline

Start
2016-07
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 2 ug/kg

Indications

No indication recorded.